Grown Rogue International (GRUSF) Shares Outstanding (Weighted Average) (2009 - 2026)

Grown Rogue International (GRUSF) recorded quarterly Shares Outstanding (Weighted Average) of $249.9 million in Q1 2026, up 6147.86% quarter-over-quarter from $4.0 million in Q4 2025, and down 99.4% on a YoY basis from $41.4 billion in Q1 2025.

Grown Rogue International (GRUSF) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends

Grown Rogue International's Shares Outstanding (Weighted Average) history runs 18 years deep, the most recent figure standing at $249.9 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) fell 99.4% year-over-year to $249.9 million; the TTM figure through Mar 2026 stood at $249.9 million (down 99.4% YoY), while the FY2025 annual figure was $4.0 million, down 99.99% from the prior year.
  • Shares Outstanding (Weighted Average) was $249.9 million for Q1 2026 at Grown Rogue International, up from $4.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $41.4 billion in Q1 2025 to a low of $4.0 million in Q4 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $7.8 billion across 5 years, with a median of $177.0 million in 2023.
  • The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Weighted Average) surged 22478.2% in 2025, then tumbled 99.4% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $128.5 million in 2022, then plunged by 81.83% to $23.3 million in 2023, then dropped by 2.54% to $22.7 million in 2024, then slumped by 82.41% to $4.0 million in 2025, then soared by 6147.86% to $249.9 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $249.9 million (Q1 2026), $4.0 million (Q4 2025), and $249.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 Grown Rogue International - - 3.96 Mn 249.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 249.91 Mn
Dec 31, 2025 4.00 Mn
Sep 30, 2025 249.56 Mn
Jun 30, 2025 246.99 Mn
Mar 31, 2025 41.36 Bn
Dec 31, 2024 22.74 Mn
Sep 30, 2024 38.61 Bn
Jun 30, 2024 27.14 Bn
Mar 31, 2024 183.18 Mn
Dec 31, 2023 23.34 Mn
Oct 31, 2023 134.23 Mn
Jul 31, 2023 170.83 Mn
Oct 31, 2022 128.47 Mn
Jan 31, 2022 164.98 Mn
Oct 31, 2021 124.83 Mn
Jul 31, 2021 163.25 Mn
Apr 30, 2021 19.20 Bn
Jan 31, 2021 14.63 Bn
Oct 31, 2020 14.42 Bn
Jul 31, 2020 14.77 Bn